期刊文献+

32例胃间质瘤的临床诊治分析

Diagnosis and treatment of gastric stromal tumor:A clinical analysis of 32 Cases
下载PDF
导出
摘要 目的:探讨胃间质瘤(GST)的临床特点及诊治方法。方法:回顾性分析我院2003-2009年外科治疗的32例GST患者的临床和病理资料。结果:本组32例均经手术治疗,手术切除率100%,术式为胃癌根治术11例,胃大部切除15例,胃局部切除6例。病理诊断良性7例,潜在恶性14例,恶性11例。免疫组化结果CD117阳性19例(59.3%),CD34阳性22例(68.7%),SMA阳性14例(43.7%),S-100阳性3例(9.3%)。结论:GST的诊断比较困难,术前确诊率低;其确诊主要依靠病理组织学检查及免疫组化染色。手术完全切除对于GST是主要的治疗方法。 Objective:To investigate the clinical features,the diagnosis and treatment of gastric stromal tumor(GST). Methods:The clinical and pathological data of 32 patients with GST were analyzed retrospectively from 2003 to 2009. Results:Surgical resection rate was 100 % in the patients. Gastric curative resection was performed in 11 cases,partial gastrectomy in 15 and local resection in 6. The pathologic diagnosis showed 7 cases of benign GST, 14 of potential malignant GST and 11 of malignant GST. The expression of CD117,CD34, SMA and S-100 was 59.3 % (19/32), 68.7% (22/32), 43.7% (14/32) and 9.3% (3/32), respectively. Conclusion : The diagnosis of GST is difficult, mainly depending on histopathotogy and immunohistochemistry, and the complete surgical resection is a primary treatment for GST.
作者 江贯中
出处 《黑龙江医药科学》 2009年第6期29-30,共2页 Heilongjiang Medicine and Pharmacy
关键词 胃肿瘤 间质瘤 免疫组化 手术治疗 stomach neoplasms stromal tumors immunohistochemistry surgical management
  • 相关文献

参考文献11

二级参考文献61

  • 1郑进军,张同琳,张自顺,周孝思.胃平滑肌肿瘤31例临床诊断分析[J].实用外科杂志,1993,13(4):213-214. 被引量:28
  • 2张权,周宁,王强,余云,杨忠民,麦月檬,邹可进,孙佑福,刘书文,翟振宇,黄灿,杨承明,李万生,刘守海,清峰,张传玲,丁章凤,周勇,李祥山,高广顺,宋守濂,方勇.胃平滑肌(肉)瘤诊治体会[J].中国实用外科杂志,1995,15(8):473-474. 被引量:22
  • 3[1]Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology[J].Hum Pathol, 1999, 30(10): 1213~1220
  • 4[2]Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J]. Science,1998, 279(5350): 577~580
  • 5[3]Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointe-stinal stromal tumours [J]. Lancet Onc, 2002, 3(11): 655~664
  • 6[4]Demetri GD. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (ST1571) [J]. Euro J Cancer,2002, 38(sup5): 52~59
  • 7[5]Kim CJ, Day S, Yeh K. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors[J]. Am Surg, 2001, 67(2): 135~138
  • 8[6]DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J]. Ann Surg, 2000, 231(1): 51~58
  • 9[7]Matthews BD, Walsh RM, Kercher KW, et al. Laparoscopic vs open resection of gastric stromal tumors[J]. Surg Endosc, 2002, 16(5): 803~807
  • 10[8]Demetri GD, Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].N EnglJ Med, 2002, 347(7): 472~480

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部